MYGN – myriad genetics, inc. (US:NASDAQ)

News

New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer [Yahoo! Finance]
New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer
Genomic Cancer Panel and Profiling Market Report 2024. by Cancer, by Application, by Tissue and by Gene Type with Screening Potential Market Size [Yahoo! Finance]
Almost 1 in 2 Americans feel they've lost time to poor mental health, survey says. It's worse for people with depression or anxiety [Yahoo! Finance]
Almost 1 in 2 Americans feel they've lost time to poor mental health, survey says. It's worse for people with depression or anxiety [Fortune]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com